ORN
Orion Group Holdings, Inc.
ORN's fundamentals are mixed, but it looks expensive: trading at 48x earnings, more than twice its usual 22x. Analysts expect strong earnings growth, though they disagree widely on how much.
ORN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Under pressure |
ORN's revenue is currently healthy, and its profitability is stable, but its cash flow and balance sheet are under pressure.
ORN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.7x | $1.40 | -82% |
| Fair | 21x | $3.30 | -57% |
| Forward | 27x | $7.65 | — |
| Current | 48x | $7.65 | — |
| Expensive | 85x | $13.65 | +78% |
Historical ranges are pointers, not guarantees.
ORN's PE is in its expensive range at 48x. If earnings grow as analysts expect, today's price would be 27x next year's earnings, in its fair range.
ORN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for ORN, with profitability holding steady. However, they disagree widely on these estimates.
ORN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.28 | +76% |
| Q3 2026 | $0.16 | -43% |
| Q2 2026 | $0.10 | -69% |
| Q1 2026 | $0.22 | +120% |
| Q4 2025 | $0.06 | +$0.11 |
| Q3 2025 | $0.28 | +$0.68 |
| Q2 2025 | $0.32 | +$0.86 |
| Q1 2025 | $0.10 | +$0.45 |
| Q4 2024 | -$0.05 | +$0.50 |
ORN's earnings per share have fallen from their peak: $0.16 over the past year, against $0.67 in late 2020.
ORN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $256.2M | +14% |
| Q2 2026 | $221.9M | +8.1% |
| Q1 2026 | $216.3M | +15% |
| Q4 2025 | $233.2M | +7.5% |
| Q3 2025 | $225.1M | -0.7% |
| Q2 2025 | $205.3M | +6.8% |
| Q1 2025 | $188.7M | +17% |
| Q4 2024 | $216.9M | +7.6% |
ORN's revenue has grown year over year for four quarters in a row: $256M last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.3% | +1 points |
| Q2 2026 | -0.6% | -2.3 points |
| Q1 2026 | -0.4% | -0.8 points |
| Q4 2025 | 2.1% | -2.3 points |
| Q3 2025 | 2.4% | -1.1 points |
| Q2 2025 | 1.7% | +3.1 points |
| Q1 2025 | 0.4% | +2.4 points |
| Q4 2024 | 4.4% | +4.7 points |
ORN's operating margin was 3.3% last quarter, up 1 points from the same quarter a year ago.
ORN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6M | -143% |
| Q2 2026 | -$29.2M | -$16.5M |
| Q1 2026 | -$3.7M | +$8.8M |
| Q4 2025 | $454K | -95% |
| Q3 2025 | $13.9M | -58% |
| Q2 2025 | -$12.7M | +$7.3M |
| Q1 2025 | -$12.5M | +$12.2M |
| Q4 2024 | $9.9M | -77% |
ORN has burned cash in most quarters: −$38M over the past year, against −$1M the year before.
ORN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +39.6K shares |
| 1 year | +1.8% | +731K shares |
| 3 years | +25% | +8.1M shares |
| 5 years | +31% | +9.5M shares |
| Available history | +38% | +11.2M shares |
ORN has 41M diluted shares, up 1.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | $164,000 |
ORN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.4x | Elevated |
| Q2 2026 | 3.8x | Elevated |
| Q1 2026 | 2.4x | Moderate |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.9x | Very low |
| Q1 2025 | 0.4x | Very low |
| Q4 2024 | -0.2x | Net Cash |
ORN's net debt is about 3.4 years of its operating earnings (EBITDA), up from less than a year a year ago.
ORN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.0 | Neutral |
| Stochastic | 13.2 | Oversold |
ORN's weekly RSI is 34 (neutral) and its Stochastic is 13 (oversold).
ORN PE vs Industrials Sector
| Metric | ORN | Sector median | Relative |
|---|---|---|---|
| PE | 48x | 24x | 99% above |
| PE % | 67 | 58 | 9 pts above |
ORN is trading at 48x earnings, a 99% premium to the Industrials sector's median of 24x.
ORN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.44 | 9.4% below |
| 20 week MA | $9.89 | 23% below |
| 50 week MA | $11.5 | 33% below |
| 100 week MA | $9.65 | 21% below |
| 200 week MA | $7.62 | 0.4% above |
ORN has fallen below most of its moving averages, though it's still 0.4% above its 200-week average.
ORN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.00 | $4.94 | -1.2% |
| 2021 | $4.94 | $3.78 | -23% |
| 2022 | $3.78 | $2.29 | -39% |
| 2023 | $2.29 | $4.94 | +116% |
| 2024 | $4.94 | $7.53 | +52% |
| 2025 | $7.53 | $10.4 | +38% |
| 2026 YTD | $10.4 | $7.65 | -27% |
ORN has finished lower in three of the last six years. It's down 27% so far in 2026.